Melanotan II is a cyclic alpha-MSH analogue investigated in early human studies of pigmentation and sexual physiology, with effects extending beyond pigment production.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Cyclic melanocortin analogue
Melanotan II is a synthetic cyclic heptapeptide derived from an alpha-MSH sequence. Its lactam bridge and modified residues distinguish it from linear Melanotan I. It is also chemically distinct from bremelanotide, so clinical findings for those other melanocortin compounds should not be assigned to this molecule.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
Melanotan II engages melanocortin-receptor signaling. Its observed effects on pigmentation, yawning, appetite-related sensations, and erections show why it should not be described solely as a skin-pigmentation peptide. Human response measurements establish biological effects, but do not independently map every contributing receptor subtype or neural circuit.
A phase-1 pilot involving three male volunteers documented pigmentation changes together with nausea, fatigue, and other responses. This tiny study supplied an initial human activity signal, not an adequate basis for broad efficacy or long-term safety conclusions. [1]
A small placebo-controlled crossover study recorded erections using objective rigidity monitoring in men without an identified organic cause of dysfunction. The findings concern an acute laboratory endpoint and should not be converted into a general sexual-performance claim. [2]
Another small crossover study included men with organic risk factors and assessed erections and reported desire. Nausea and other effects remained prominent. It extended the studied population but did not establish durable symptom improvement or comparative clinical effectiveness. [3]
Study topics describe the cited models, not established benefits of this catalog material.
The cited evidence directly concerns Melanotan II, but consists of small exploratory studies with short observation periods. These experiments support melanocortin-related biological activity across more than one system. They cannot establish a complete safety profile, reliable long-term outcomes, or equivalence to another melanocortin medicine.
Pigmentation does not establish protection from skin cancer or other effects of ultraviolet exposure. Acute erection measurements are different from patient-centered outcomes over time. The historical studies do not verify WYZ Labs identity, purity, or batch documentation, and provide no basis for personal-use instructions.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Three-person pilot defining the cyclic peptide and documenting pigmentation and non-pigment effects.
Small acute rigidity-monitoring study; does not establish long-term clinical outcomes.
Small crossover study with organic risk factors; nausea was a relevant observed effect.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAOther single compounds in the collection.
Metabolic Research
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
Metabolic Research
MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling and skeletal-muscle adaptation, with experimental interventions supported mainly by cell and animal evidence.
Dermal Research
GHK-Cu is a copper complex of glycyl-histidyl-lysine studied for its effects on extracellular-matrix production and remodeling in experimental tissue-repair systems.
